Hallmarks Of Aging In Systemic Sclerosis: Implications For Pathogenesis, Multimorbidity, And Therapeutic Development
Have you ever wondered how the natural process of aging might influence complex diseases? Recent research sheds light on how fundamental aging mechanisms contribute to a condition called systemic sclerosis, a chronic autoimmune disease that causes hardening and tightening of the skin and internal organs. It turns out that certain “hallmarks of aging” are deeply involved in this disease.
One key player is cellular senescence, often referred to as “zombie cells.” These are cells that have stopped dividing but don’t die off. Instead, they linger and release harmful inflammatory substances that can damage surrounding healthy tissues. In systemic sclerosis, the accumulation of these senescent cells in affected organs contributes to the characteristic scarring (fibrosis) and blood vessel damage.
Another important factor is telomere dysfunction. Telomeres are protective caps at the ends of our chromosomes, like the plastic tips on shoelaces, safeguarding our genetic material. As we age, or due to various stressors, these telomeres naturally shorten. In individuals with systemic sclerosis, particularly those with lung involvement, these telomeres are often found to be shorter, and this shortening is linked to how severe the disease is and patient outcomes.
Understanding how these aging processes fuel the disease provides exciting new avenues for medicine. By recognizing the role of cellular senescence and telomere issues, scientists hope to develop better ways to predict how the disease will progress, identify patients who might benefit most from specific treatments, and even create new therapies that target these aging pathways to slow down or halt the disease progression.
Source: link to paper